Ultradian Diagnostics (United States)
- Research works
- 0 fractional, all time
- Citations
- 1 3.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: Ultradian Diagnostics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Ultradian Diagnostics (United States) publish most on?
By volume: Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients and Spectroscopy Techniques in Biomedical and Chemical Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 2 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
- 3 Spectroscopy Techniques in Biomedical and Chemical Research Biophysics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
Other research institutions in Rensselaer
- Neural Stem Cell Institute
- New York State Office of Children and Family Services
- Healthcare Association of New York State
- Pulmokine (United States)
- SyntheZyme (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.